FORM 6-K/A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the Month of September, 2012
Commission File Number 1-32001
Lorus Therapeutics Inc.
(Translation of registrant’s name into English)
2 Meridian Road, Toronto, Ontario M9W 4Z7
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x | Form 40-F o |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
EXPLANATORY NOTE
In respect to comments received from the staff of the SEC, this Form 6-K/A is being furnished to (i) amend the Form 6-K previously furnished by Lorus Therapeutics Inc. (the "Corporation") on November 16, 2009, in order to re-file Exhibits 99.2 through 99.7 thereto which have been filed as Exhibits 99.1 through 99.6 of this Form 6-K/A (ii) amend the Form 6-K previously furnished by the corporation on April 21, 2008 in order to re-file Exhibits 99.1 through 99.3 thereto which have been filed as Exhibit 99.7, 99.8 and 99.9 of this Form 6-K/A.
DOCUMENTS FILED AS PART OF THIS FORM 6-K/A
See Exhibit Index hereto
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Lorus Therapeutics Inc. | ||
Date: September 27, 2012 | By: | /s/ “Elizabeth Williams” |
Elizabeth Williams | ||
Director of Finance and Controller |
EXHIBIT INDEX
99.1 | Animal Rights Licence Agreement dated June 19, 2009 |
99.2* | Asset Purchase Agreement dated June 19, 2009 |
99.3* | Amendment, Assignment, Assumption Novation and Consent Agreement dated June 19, 2009 |
99.4* | Settlement Agreement dated June 19, 2009 |
99.5* | Share Purchase Agreement dated June 19, 2009 |
99.6* | Supply and Services Agreement dated June 19, 2009 |
99.7* | Licence Agreement dated April 8, 2008 |
99.8* | Zor Pharmaceuticals, LLC Limited Liability Company Agreement |
99.9* | Independent Contractor Service Agreement |
* Confidential treatment has been requestd for parts of this document, which are omitted and filed separately with the SEC.